CARACO PHARMACEUTICAL LABORATORIES LTD (CPD) is a publicly traded company in the Unknown sector. Across all available filings, 13 corporate insiders have executed 214 transactions totaling $1.3M, demonstrating a bearish sentiment with -$1.2M in net insider flow. The most recent transaction on Jun 14, 2011 involved a transaction of 9,710,614 shares valued at $0.
No significant insider buying has been recorded for CPD in the recent period.
No significant insider selling has been recorded for CPD in the recent period.
Based on recent SEC filings, insider sentiment for CPD is bearish with an Insider Alignment Score of 3/100 and a net flow of -$1.2M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at CARACO PHARMACEUTICAL LABORATORIES LTD (CPD) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 13 insiders are actively trading CPD stock, having executed 214 transactions in the past 90 days. The most active insider is Jitendra N. Doshi (Executive), who has made 38 transactions totaling $672.1K.
Get notified when executives and directors at CPD file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jun 14, 2011 | S. Shanghvi Dilip | Executive | Other | 9,710,614 | $N/A | $0 | |
| Jun 14, 2011 | Manney Tim | Executive | Other | 10,000 | $N/A | $0 | |
| Jun 14, 2011 | Manney Tim | Executive | Other | 5,000 | $N/A | $0 | |
| Jun 14, 2011 | Folsom Bell F. | Executive | Other | 5,000 | $N/A | $0 | |
| Jun 14, 2011 | Singh Sachdeva Gurpartap | Executive | Other | 10,000 | $N/A | $0 | |
| Jun 14, 2011 | Singh Sachdeva Gurpartap | Executive | Other | 1,800 | $N/A | $0 | |
| Jun 14, 2011 | R. Munson Eddie | Executive | Other | 5,000 | $N/A | $0 | |
| Jun 14, 2011 | Kurkiewicz Robert | Executive | Other | 7,013 | $N/A | $0 | |
| Jun 14, 2011 | Folsom Bell F. | Executive | Other | 5,000 | $N/A | $0 | |
| Jun 14, 2011 | Singh Sachdeva Gurpartap | Executive | Other | 10,000 | $N/A | $0 | |
| Jun 14, 2011 | Singh Sachdeva Gurpartap | Executive | Other | 1,800 | $N/A | $0 | |
| Jun 14, 2011 | Manney Tim | Executive | Other | 10,000 | $N/A | $0 | |
| Jun 14, 2011 | Manney Tim | Executive | Other | 5,000 | $N/A | $0 | |
| Dec 5, 2010 | Industries Ltd Sun Pharmaceutical | Executive | Conversion | 544,000 | $N/A | $0 | |
| Sep 14, 2010 | Manney Tim | Executive | Award | 5,000 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 168 | $1.3M | 87.8% |
Exercise(M) | 9 | $133.0K | 9.2% |
Purchase(P) | 7 | $42.7K | 3.0% |
Other(J) | 13 | $0 | 0.0% |
Conversion(C) | 13 | $0 | 0.0% |
Award(A) | 4 | $0 | 0.0% |
Insider selling pressure at CARACO PHARMACEUTICAL LABORATORIES LTD has increased, with 13 insiders executing 214 transactions across all time. Total sales of $1.3M significantly outpace purchases of $42.7K, resulting in a net outflow of $1.2M. This selling activity appears largely discretionary, which may warrant closer attention from investors.